Characteristics and Burden of Macro, Micro, and Normoalbuminuria in Patients with Type 2 Diabetes (T2D)

被引:0
|
作者
Blonde, Lawrence
Wilk, Alan
Bogdanov, Alina
Vasey, Joe
Kallenbach, Lee
Durkin, Michael
机构
关键词
D O I
10.2337/db20-1517-P
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1517-P
引用
收藏
页数:2
相关论文
共 50 条
  • [1] CHARACTERISTICS OF US COMMERCIALLY INSURED PATIENTS WITH TYPE 2 DIABETES (T2D) INITIATING TIRZEPATIDE
    Desai, K.
    Mody, R.
    Teng, C. C.
    Benneyworth, B.
    Reznor, G.
    Stockbower, G.
    Grabner, M.
    [J]. VALUE IN HEALTH, 2024, 27 (06) : S223 - S223
  • [2] Mechanisms of the Antihyperglycemic Effect of Sitagliptin in Patients with Type 2 Diabetes (T2D)
    Muscelli, Elza
    Casolaro, Arturo
    Gastaldelli, Amalia
    Mari, Andrea
    Seghieri, Giuseppe
    Chen, Yu
    Alba, Maria
    Holst, Jens
    Ferrannini, Ele
    [J]. DIABETES, 2011, 60 : A267 - A267
  • [3] Dapagliflozin (DAPA) in Patients with Type 2 Diabetes (T2D) and Mixed Dyslipidemia
    Bays, Harold E.
    Sartipy, Peter
    Xu, John
    Langkilde, Anna Maria
    Sjostrom, C. David
    [J]. DIABETES, 2016, 65 : A306 - A306
  • [4] Diabetes Management in Hospitalized Patients with Type 2 Diabetes (T2D) during Fasting Periods
    Rainer, Raphael
    Elsayed, Hesham
    Aberer, Felix
    Beck, Peter
    Pieber, Thomas R.
    Donsa, Klaus
    Plank, Johannes
    Mader, Julia K.
    [J]. DIABETES, 2018, 67
  • [5] CHARACTERISTICS OF FINERENONE INITIATORS AMONG PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD) AND TYPE 2 DIABETES (T2D)
    Teng, Chia-Chen
    Singh, Rakesh
    Kong, Sheldon
    Djaraher, Rachel
    Williamson, Todd
    Farej, Ryan
    Willey, Vincent
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2023, 81 (04) : S75 - S75
  • [6] Treatment Patterns and Characteristics of Patients with Type 2 Diabetes (T2D) Managed with Basal-Bolus Therapy in the
    Van Brunt, Kate
    Curtis, Bradley H.
    Chalkiadaki, Corina
    Balogh, Elemer
    Ivanyi, Tibor
    Raluy, Mireia
    Maclachlan, Sharon
    [J]. DIABETES, 2015, 64 : A696 - A697
  • [8] TYPE 2 DIABETES PATIENTS SUBCLASSIFICATION ANALYSIS: PERSONALIZED T2D CARE OF DORZAGLIATIN
    Feng, L.
    Chen, C.
    Chen, L.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A87 - A87
  • [9] Effect of Sotagliflozin (SOTA) on Albuminuria in Patients With Type 2 Diabetes (T2D) and CKD
    Cherney, David
    Bhatt, Deepak L.
    Szarek, Michael
    Sun, Franklin W.
    Davies, Michael J.
    Pitt, Bertram
    Steg, Philippe Gabriel
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 675 - 675
  • [10] Dapagliflozin and measures of cardiovascular autonomic function in patients with type 2 diabetes (T2D)
    Ang, Lynn
    Kidwell, Kelley M.
    Dillon, Brendan
    Reiss, Jacob
    Fang, Fang
    Leone, Virginia
    Mizokami-Stout, Kara
    Pop-Busui, Rodica
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2021, 35 (08)